Send feedback

SPAST p.Ser17Arg

c.51C>G · rs1303074496 · VCV1428531

Likely benign Single submitter
Classification
Likely benign
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely benign
0.2892 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00269%, afr)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
hereditary spastic paraplegia 4

Computational evidence

Protein change
AlphaMissense0.2892likely benign
REVEL0.207benign-leaning
SaProtLLR -5.85tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 3.4GERP 1.7, phastCons 1
Regional constrainto/e 1.22unconstrained · MANE · 52 kb · p 3.5e-06 · regional, not allelic
Overall
CADD23.3PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00269% African / African-American · 2/74,440 alleles
Filtering AF 0.000446% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.000167%
Overall 0.000126% 2/1,583,584 alleles · very rare exomes 1/1,431,734 · genomes 1/151,850 · joint denominator

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
SPAST
Protein
p.Ser17Arg
Coding
c.51C>G
MANE Select
NM_014946
dbSNP
rs1303074496
Type
single nucleotide variant
Location
chr2:32063882 (GRCh38)
Gene constraint
LOEUF 0.69 · pLI 0.11 · ClinGen HI 3/3 (gnomAD)
Structure
AlphaFold pLDDT 77.03 · 7 PDB
Residue 17
the 'required for interaction with rtn1' region; the 'required for midbody localization' region; the 'required for interaction with atl1' region; the 'required for nuclear localization' region; the 'disordered' region
Full SPAST gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

hereditary spastic paraplegia 4 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Autosomal dominant spastic paraplegia type 4 (Orphanet):

Inheritance
Autosomal dominant
Onset
Adolescent, Adult, Childhood, Infancy
Prevalence
1-9 / 1 000 000 (Portugal)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/spast-p-ser17arg (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown